BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23980092)

  • 1. Stomach cancer risk after treatment for hodgkin lymphoma.
    Morton LM; Dores GM; Curtis RE; Lynch CF; Stovall M; Hall P; Gilbert ES; Hodgson DC; Storm HH; Johannesen TB; Smith SA; Weathers RE; Andersson M; Fossa SD; Hauptmann M; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Pukkala E; Vaalavirta L; van den Belt-Dusebout AW; Fraumeni JF; Travis LB; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2013 Sep; 31(27):3369-77. PubMed ID: 23980092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
    Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
    JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
    Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer risk after treatment of Hodgkin lymphoma.
    Dores GM; Curtis RE; van Leeuwen FE; Stovall M; Hall P; Lynch CF; Smith SA; Weathers RE; Storm HH; Hodgson DC; Kleinerman RA; Joensuu H; Johannesen TB; Andersson M; Holowaty EJ; Kaijser M; Pukkala E; Vaalavirta L; Fossa SD; Langmark F; Travis LB; Fraumeni JF; Aleman BM; Morton LM; Gilbert ES
    Ann Oncol; 2014 Oct; 25(10):2073-2079. PubMed ID: 25185241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.
    Gilbert ES; Curtis RE; Hauptmann M; Kleinerman RA; Lynch CF; Stovall M; Smith SA; Weathers R; Andersson M; Dores GM; Fraumeni JF; Fossa SD; Hall P; Hodgson DC; Holowaty EJ; Joensuu H; Johannesen TB; Langmark F; Kaijser M; Pukkala E; Rajaraman P; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Aleman BM; Travis LB; Morton LM; van Leeuwen FE
    Radiat Res; 2017 Feb; 187(2):186-195. PubMed ID: 28118119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
    J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
    Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
    JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
    Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
    Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
    J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
    J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
    Chronowski GM; Wilder RB; Levy LB; Atkinson EN; Ha CS; Hagemeister FB; Barista I; Rodriguez MA; Sarris AH; Hess MA; Cabanillas F; Cox JD
    Am J Clin Oncol; 2004 Feb; 27(1):73-80. PubMed ID: 14758137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Koontz MZ; Horning SJ; Balise R; Greenberg PL; Rosenberg SA; Hoppe RT; Advani RH
    J Clin Oncol; 2013 Feb; 31(5):592-8. PubMed ID: 23295809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study.
    Reulen RC; Winter DL; Diallo I; Veres C; Llanas D; Allodji RS; Bagnasco F; Bárdi E; Feijen EAM; Alessi D; Fidler-Benaoudia MM; Høgsholt S; Teepen JC; Linge H; Haddy N; Byrne J; Debiche G; Grabow D; Gudmundsdottir T; Fauchery R; Zrafi W; Michel G; Øfstaas H; Kaatsch P; Vu-Bezin G; Jenkinson H; Kaiser M; Skinner R; Cole T; Waespe N; Sommer G; Nordenfelt S; Jankovic M; Lähteenmäki Taalas T; Maule MM; van der Pal HJH; Ronckers CM; van Leeuwen FE; Kok JL; Terenziani M; Winther Gunnes M; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki PM; Zadravec Zaletel L; Kuehni CE; Winther JF; Kremer LCM; Hjorth L; de Vathaire F; Hawkins MM
    J Clin Oncol; 2023 Jul; 41(21):3735-3746. PubMed ID: 37235821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
    van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
    Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Dahler EC; van't Veer MB; Noordijk EM; Crommelin MA; Aleman BM; Broeks A; Gospodarowicz M; Travis LB; Russell NS
    J Natl Cancer Inst; 2003 Jul; 95(13):971-80. PubMed ID: 12837833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.